| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 653830 | 67561 | BROMURO DE IPRATROPIO ALDO-UNION 250 microgramos/ml SOLUCION PARA INHALACION POR NEBULIZADOR | BROMURO DE IPRATROPIO ALDO-UNION 250 microgramos/ml SOLUCION PARA INHALACION POR NEBULIZADOR , 20 ampollas de 1 ml | 250 microgramos | 1 | 20 | 40 | 20 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67561/67561_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67561/67561_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16620 | LABORATORIO ALDO UNION S.L. | 2006-02-15 | 1 | 1 | 1 | 2006-02-15 | 2006-02-15 | 1 | 2011-07-14 | View Edit Delete | ||||||||||||
| 652764 | 67260 | FLUMAZENILO FRESENIUS KABI 0,1 mg/ml INYECTABLE EFG | FLUMAZENILO FRESENIUS KABI 0,1 mg/ml INYECTABLE EFG , 5 ampollas de 5 ml | 0,1 mg/ml inyectable 5 ml | 1 | 5 | 1 | 5 ampollas de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67260/67260_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67260/67260_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2005-11-23 | 1 | 1 | 1 | 2005-11-23 | 2005-11-23 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 654320 | 55890 | HMG-LEPORI 75 U.I. POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | HMG-LEPORI 75 U.I. POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 10 ampollas + 10 ampollas de disolvente | 75 UI | 1 | 10 | 1 | 10 ampollas + 10 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/55890/55890_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/55890/55890_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39341 | ANGELINI PHARMA ESPANA S.L. | 1982-05-01 | 1 | 1 | 1 | 1982-05-01 | 2012-05-21 | 1 | 2012-07-25 | 886028, 656812, 663416 | View Edit Delete | |||||||||||
| 653570 | 67459 | VIAFLO CLORURO SODICO 0,9% Y CLORURO POTASICO 0,15%, SOLUCION PARA PERFUSION | VIAFLO CLORURO SODICO 0,9% Y CLORURO POTASICO 0,15%, SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | 0,9% + 10 mEq/500 ml | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67459/67459_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67459/67459_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2006-01-18 | 1 | 1 | 1 | 2006-01-18 | 2006-01-18 | 0 | 2011-06-24 | View Edit Delete | ||||||||||||
| 654436 | 67821 | VIAFLO PLASMALYTE 148 (PH 7,4), SOLUCION PARA PERFUSION | VIAFLO PLASMALYTE 148 (PH 7,4), SOLUCION PARA PERFUSION, 20 bolsas de 500 ml | N/A (más de 4 PA) | 3 | 20 | 65 | 20 bolsas de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67821/67821_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67821/67821_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2006-05-22 | 1 | 1 | 1 | 2006-05-22 | 2006-05-22 | 1 | 2011-06-24 | View Edit Delete | ||||||||||||
| 652656 | 67213 | PRIOSOL CON 4 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL CON 4 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67213/67213_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67213/67213_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 652658 | 67214 | PRIOSOL CON 2 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL CON 2 mmol/L DE POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67214/67214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67214/67214_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 652659 | 67215 | PRIOSOL SIN POTASIO SOLUCION PARA HEMOFILTRACION | PRIOSOL SIN POTASIO SOLUCION PARA HEMOFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67215/67215_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67215/67215_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9126 | B BRAUN MEDICAL S.A. | 2005-11-15 | 1 | 1 | 1 | 2005-11-15 | 2005-11-15 | 0 | 2012-01-09 | View Edit Delete | ||||||||||||
| 653975 | 67610 | ACCUSOL 35 SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | 0,343 mg/ml + 0,136 mg/ml + 7,52 mg/ml + 13,4 mg/ml inyectable 5.000 ml | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67610/67610_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67610/67610_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2012-04-18 | View Edit Delete | ||||||||||||
| 653976 | 67611 | ACCUSOL 35 POTASIO 2 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 POTASIO 2 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67611/67611_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67611/67611_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2012-04-18 | View Edit Delete | ||||||||||||
| 653977 | 67612 | ACCUSOL 35 POTASIO 4 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION | ACCUSOL 35 POTASIO 4 mmol/L SOLUCION PARA HEMOFILTRACION, HEMODIALISIS Y HEMODIAFILTRACION , 2 bolsas de 5.000 ml | N/A (más de 4 PA) | 3 | 2 | 65 | 2 bolsas de 5.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67612/67612_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67612/67612_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 17503 | PALEX MEDICAL S.A. | 2006-03-16 | 1 | 1 | 1 | 2006-03-16 | 2006-03-16 | 1 | 2019-06-12 | View Edit Delete | ||||||||||||
| 653906 | 67589 | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EBASTINA ALTER 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 10 mg | 4 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67589/67589_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67589/67589_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2006-03-01 | 1 | 1 | 1 | 2006-03-01 | 2006-03-01 | 1 | 2011-11-11 | View Edit Delete | ||||||||||||
| 652664 | 67219 | DIARFIN 2 mg CAPSULAS DURAS | DIARFIN 2 mg CAPSULAS DURAS , 20 cápsulas | 2 mg | 5 | 20 | 43 | 20 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67219/67219_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67219/67219_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2005-11-16 | 1 | 1 | 1 | 2005-11-16 | 2005-11-16 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 652798 | 67278 | IBUPROFENO CINFAMED 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IBUPROFENO CINFAMED 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 30 comprimidos | 400 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67278/67278_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67278/67278_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2005-11-28 | 1 | 1 | 1 | 2005-11-28 | 2005-11-28 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 652848 | 67308 | TAMSULOSINA CINFA 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG | TAMSULOSINA CINFA 0,4 mg CAPSULAS DURAS DE LIBERACION MODIFICADA EFG, 30 cápsulas (PVC/PE/PVDC/AL) | 0,4 mg | 5 | 30 | 43 | 30 cápsulas (PVC/PE/PVDC/AL) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67308/67308_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67308/67308_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2005-12-01 | 1 | 1 | 1 | 2005-12-01 | 2005-12-01 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 653397 | 65460 | AMLODIPINO CINFA 5 mg COMPRIMIDOS EFG | AMLODIPINO CINFA 5 mg COMPRIMIDOS EFG , 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65460/65460_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65460/65460_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2003-07-01 | 1 | 1 | 1 | 2003-07-01 | 2006-08-02 | 1 | 2011-10-19 | 859413 | View Edit Delete | |||||||||||
| 653398 | 65461 | AMLODIPINO CINFA 10 mg COMPRIMIDOS EFG | AMLODIPINO CINFA 10 mg COMPRIMIDOS EFG , 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65461/65461_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65461/65461_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2003-07-02 | 1 | 1 | 1 | 2003-07-02 | 2006-08-02 | 1 | 2011-10-19 | 859454 | View Edit Delete | |||||||||||
| 653686 | 67511 | GLIMEPIRIDA CINFA 4 mg COMPRIMIDOS EFG | GLIMEPIRIDA CINFA 4 mg COMPRIMIDOS EFG, 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67511/67511_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67511/67511_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-01-27 | 1 | 1 | 1 | 2006-01-27 | 2006-01-27 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 653687 | 67511 | GLIMEPIRIDA CINFA 4 mg COMPRIMIDOS EFG | GLIMEPIRIDA CINFA 4 mg COMPRIMIDOS EFG, 120 comprimidos | 4 mg | 5 | 120 | 10 | 120 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67511/67511_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67511/67511_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-01-27 | 1 | 1 | 1 | 2006-01-27 | 2006-01-27 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 653688 | 67512 | GLIMEPIRIDA CINFA 2 mg COMPRIMIDOS EFG | GLIMEPIRIDA CINFA 2 mg COMPRIMIDOS EFG, 30 comprimidos | 2 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67512/67512_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67512/67512_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-01-27 | 1 | 1 | 1 | 2006-01-27 | 2006-01-27 | 1 | 2011-10-19 | View Edit Delete |
Page 90 of 1035, showing 20 records out of 20689 total, starting on record 1781, ending on 1800